Literature DB >> 25229693

Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy.

Nathan D Roe1, Xihui Xu1, Machender R Kandadi1, Nan Hu1, Jiaojiao Pang2, Mary C M Weiser-Evans3, Jun Ren4.   

Abstract

Phosphatase and tensin homolog (PTEN) deleted from chromosome 10 has been implicated in the maintenance of cardiac homeostasis although the underlying mechanism(s) remains elusive. We generated a murine model of cardiomyocyte-specific knockout of PTEN to evaluate cardiac geometry and contractile function, as well as the effect of metformin on PTEN deficiency-induced cardiac anomalies, if any. Cardiac histology, autophagy and related signaling molecules were evaluated. Cardiomyocyte-specific PTEN deletion elicited cardiac hypertrophy and contractile anomalies (echocardiographic and cardiomyocyte contractile dysfunction) associated with compromised intracellular Ca(2+) handling. PTEN deletion-induced cardiac hypertrophy and contractile anomalies were associated with dampened phosphorylation of PTEN-inducible kinase 1 (Pink1) and AMPK. Interestingly, administration of AMPK activator metformin (200mg/kg/d, in drinking H2O for 4weeks) rescued against PTEN deletion-induced geometric and functional defects as well as interrupted autophagy and autophagic flux in the heart. Moreover, metformin administration partially although significantly attenuated PTEN deletion-induced accumulation of superoxide. RNA interference against Pink1 in H9C2 myoblasts overtly increased intracellular ATP levels and suppressed AMPK phosphorylation, confirming the role of AMPK as a downstream target for PTEN-Pink1. Further scrutiny revealed that activation of AMPK and autophagy using metformin and rapamycin, respectively, rescued against PTEN deletion-induced mechanical anomalies with little additive effect. These data demonstrated that cardiomyocyte-specific deletion of PTEN leads to the loss of Pink1-AMPK signaling, development of cardiac hypertrophy and contractile defect. Activation of AMPK rescued against PTEN deletion-induced cardiac anomalies associated with restoration of autophagy and autophagic flux. This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPK; Cardiac hypertrophy; Contractile function; PTEN; Pink1

Mesh:

Substances:

Year:  2014        PMID: 25229693      PMCID: PMC4277923          DOI: 10.1016/j.bbadis.2014.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

Review 1.  Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart.

Authors:  Wajihah Mughal; Rimpy Dhingra; Lorrie A Kirshenbaum
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 2.  Unmasking the janus faces of autophagy in obesity-associated insulin resistance and cardiac dysfunction.

Authors:  Xihui Xu; Jun Ren
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-02       Impact factor: 2.557

3.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy.

Authors:  Zhonglin Xie; Chaoyong He; Ming-Hui Zou
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

5.  Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling.

Authors:  J Wang; L Yang; A R Rezaie; J Li
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  Effects of chronic Akt activation on glucose uptake in the heart.

Authors:  Takashi Matsui; Tomohisa Nagoshi; Eun-Gyoung Hong; Ivan Luptak; Kirsten Hartil; Ling Li; Naira Gorovits; Maureen J Charron; Jason K Kim; Rong Tian; Anthony Rosenzweig
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-13       Impact factor: 4.310

7.  Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.

Authors:  Heng Ma; Jingying Wang; D Paul Thomas; Chao Tong; Lin Leng; Wenkui Wang; Melanie Merk; Swen Zierow; Jürgen Bernhagen; Jun Ren; Richard Bucala; Ji Li
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

8.  Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.

Authors:  Gavin Y Oudit; Zamaneh Kassiri; Joyce Zhou; Qiao C Liu; Peter P Liu; Peter H Backx; Fayez Dawood; Michael A Crackower; James W Scholey; Josef M Penninger
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

9.  Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.

Authors:  Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark D Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

10.  Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice.

Authors:  Zhonglin Xie; Kai Lau; Bonnie Eby; Pedro Lozano; Chaoyong He; Becky Pennington; Hongliang Li; Shradha Rathi; Yunzhou Dong; Rong Tian; David Kem; Ming-Hui Zou
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

View more
  22 in total

Review 1.  Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.

Authors:  Francisco Westermeier; Mario Navarro-Marquez; Camila López-Crisosto; Roberto Bravo-Sagua; Clara Quiroga; Mario Bustamante; Hugo E Verdejo; Ricardo Zalaquett; Mauricio Ibacache; Valentina Parra; Pablo F Castro; Beverly A Rothermel; Joseph A Hill; Sergio Lavandero
Journal:  Biochim Biophys Acta       Date:  2015-02-14

2.  Unsupervised classification of multi-omics data during cardiac remodeling using deep learning.

Authors:  Neo Christopher Chung; Bilal Mirza; Howard Choi; Jie Wang; Ding Wang; Peipei Ping; Wei Wang
Journal:  Methods       Date:  2019-03-07       Impact factor: 3.608

Review 3.  The role of autophagy in cardiac hypertrophy.

Authors:  Lanfang Li; Jin Xu; Lu He; Lijun Peng; Qiaoqing Zhong; Linxi Chen; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-15       Impact factor: 3.848

4.  PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury.

Authors:  Wenshuai Tang; Deqing Lin; Mingxiang Chen; Zhiping Li; Weimin Zhang; Wenping Hu; Fuping Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-20       Impact factor: 2.416

5.  ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway.

Authors:  Xiao Han; Yun-Long Zhang; Qiu-Yue Lin; Hui-Hua Li; Shu-Bin Guo
Journal:  Cell Biol Toxicol       Date:  2022-02-26       Impact factor: 6.691

6.  mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1.

Authors:  Qiurong Wang; Jun Ren
Journal:  Pharmacol Res       Date:  2016-06-27       Impact factor: 7.658

7.  AMPK controls the axonal regenerative ability of dorsal root ganglia sensory neurons after spinal cord injury.

Authors:  Guiping Kong; Luming Zhou; Elisabeth Serger; Ilaria Palmisano; Francesco De Virgiliis; Thomas H Hutson; Eilidh Mclachlan; Anja Freiwald; Paolo La Montanara; Kirill Shkura; Radhika Puttagunta; Simone Di Giovanni
Journal:  Nat Metab       Date:  2020-08-10

Review 8.  Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.

Authors:  Xuejun Wang; Taixing Cui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-02       Impact factor: 4.733

Review 9.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

10.  Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy.

Authors:  Maria Lombardi; Davide Lazzeroni; Giulia Benedetti; Gloria Bertoli; Dejan Lazarevic; Michela Riba; Francesco De Cobelli; Ornella Rimoldi; Giulia d'Amati; Iacopo Olivotto; Chiara Foglieni; Paolo Camici
Journal:  Clin Transl Med       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.